RE: 3D..ramper?13 Apr 2024 21:00
BRV,
Thanks for the reply :)
Enjoyable and informative in equal measure!
Things looked very different when we had a large wedge to spend as required, its rather frustrating that we have reached a point where once again cash is a consideration, without yet having performed a flow test of any description.
My concern is that the drilling window and testing schedule (expectation 21 days) look to be almost in overlap.
Wiggle room will be at a minimum.
Significant intervals appear set to remain untested, presumably to preserve cash.
The drilling of MOU5 is of course necessary, more than that, hugely important. But flow testing extensively - far more so. Also coming with far less risk, or with a greater CoS, when the companys cash position is so precarious.
I dont disagree with anything you say, other than to point out that the risk associated with testing doesn't end once the formation is breached. We require consistent flow and continuity of supply from multiple sources. To achieve this, some degree of remedial work, minor or major, wouldn't be a surprise.
We are being shoehorned into small windows of activity by this bonkers regulatory extension process, which caused Paul to abandon testing, standing down testing equipment and personnel last year, and again delaying the same activity this year. Another cut off looms, coming at a rather inopportune time, again with the potential for disruption.
It all feels like trying to thread a needle with the lights off.
Any issue with MOU5, with cash in your pocket, is surmountable and a temporary setback - SP holds. Better to approach from a position of strength imo.
Similarly, with testing, RNS: We encountered difficulty with X and have already moved to resolve, SP holds, no problem.
Raising on the back of adverse news must be avoided. The dilutary impact of even a small raise, particularly from a low base, is exponential on final value.